Dr. Chow Seng Kong

Chow Seng is a scientific co-founder of Xambika and a key driver of its translational innovation. An expert in reproductive biology and molecular diagnostics, his research centres on the endometrial environment in women experiencing fertility challenges. As a lead scientist and co-inventor on a biomarker-based patent, he has worked closely with clinicians to develop and validate the PRELI test for clinical use. At Xambika, he bridges science and strategy — shaping commercial development, supporting regulatory planning, and ensuring evidence-based decision-making.